C Perisanidis
Overview
Explore the profile of C Perisanidis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
320
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Papadiochou S, Papadiochos I, Perisanidis C, Papadogeorgakis N
Br J Oral Maxillofac Surg
. 2019 Dec;
58(1):3-24.
PMID: 31785865
Medical practitioners' (MP) role is pivotal in primary prevention, early diagnosis, prompt referral and effective management of oral and oropharyngeal carcinomas (OC/OPC), which raises the importance of their effective OC/OPC...
2.
Russmueller G, Winkler L, Lieber R, Seemann R, Pirklbauer K, Perisanidis C, et al.
Eur Cell Mater
. 2017 Oct;
34:291-306.
PMID: 29064533
Much research has been done on bone cells, but only a few studies deal with biomaterial-induced effects on human osteoclasts, which may take on an important role in the successful...
3.
Fochtmann-Frana A, Haymerle G, Loewe R, Grasl M, Pammer J, Rath T, et al.
Clin Otolaryngol
. 2017 Oct;
43(2):678-682.
PMID: 28981217
No abstract available.
4.
Strati A, Koutsodontis G, Papaxoinis G, Angelidis I, Zavridou M, Economopoulou P, et al.
Ann Oncol
. 2017 Aug;
28(8):1923-1933.
PMID: 28838214
Background: Successful application of programmed death 1 (PD1) checkpoint inhibitors in the clinic may ultimately benefit from appropriate patient selection based upon predictive biomarkers. Molecular characterization of circulating tumor cells...
5.
Nemeth D, Zaleczna L, Huremovic A, Engelmann J, Poeschl P, Strasz M, et al.
Int J Oral Maxillofac Surg
. 2017 Jun;
46(10):1229-1236.
PMID: 28579265
The primary objective of this study was to investigate the quality of life (QOL) of patients with oral squamous cell carcinoma (OSCC) undergoing curative neoadjuvant chemoradiotherapy followed by radical tumour...
6.
Economopoulou P, Agelaki S, Perisanidis C, Giotakis E, Psyrri A
Ann Oncol
. 2016 Jul;
27(9):1675-85.
PMID: 27380958
Squamous cell cancers of the head and neck (HNSCC) comprise a diverse group of malignancies that includes tobacco-related tumors in addition to an increasing number of human papillomavirus-associated cancers. Independently...
7.
Perisanidis C, Psyrri A, Cohen E, Engelmann J, Heinze G, Perisanidis B, et al.
Cancer Treat Rev
. 2015 Nov;
41(10):960-70.
PMID: 26604093
Background: Plasma fibrinogen may be involved in several stages of cancer progression. Clinical studies have demonstrated that pretreatment plasma fibrinogen is associated with poor survival in various cancers. The aim...
8.
Russmueller G, Moser D, Spassova E, Plasenzotti R, Poeschl P, Seemann R, et al.
J Craniomaxillofac Surg
. 2015 May;
43(5):696-704.
PMID: 25937475
The present study investigated the suitability of three different absorbable biocomposites for the repair of critical sized bone defects created at the mandibular angle of adult sheep. Each biocomposite was...
9.
Russmueller G, Moser D, Wurger T, Wrba F, Christopoulos P, Kostakis G, et al.
Oral Oncol
. 2014 Dec;
51(3):247-53.
PMID: 25532817
Objectives: We aimed to determine the prognostic significance of receptor activator of nuclear factor kappa-B ligand (RANKL), RANK and osteoprotegerin (OPG) in patients with oral squamous cell carcinoma (OSCC). Materials...
10.
Kanatas A, Perisanidis C, Fabbroni G
Br J Oral Maxillofac Surg
. 2013 Mar;
51(6):570-1.
PMID: 23473883
No abstract available.